Lana Popova

Proteomics-directed cloning of circulating antiviral human monoclonal antibodies

1. Trapnell, C. et al. Nat. Biotechnol. 28, 511–515 (2010). 2. Trapnell, C. et al. Nat. Protoc. 7, 562–578 (2012). 3. Nielsen, C.B., Cantor, M., Dubchak, I., Gordon, D. & Wang, T. Nat. Methods 7, S5–S15 (2010). 4. Rutherford, K. et al. Bioinformatics 16, 944–945 (2000). 5. Kent, W.J. Genome Res. 12, 996–1006 (2002). 6. Robinson, J.T. et al. Nat. Biotechnol. 29, 24–26 (2011). 7. Fiume, M., Williams, V., Brook, A. & Brudno, M. Bioinformatics 26, 1938–1944 (2010). 8. Jankun-Kelly, T.J. & Kwan-Liu, M. IEEE Transactions on Visualization and Computer Graphics 7, 275–287 (2001). 9. Pretorius, A.J., Bray, M.A.P., Carpenter, A.E. & Ruddle, R.A. IEEE Transactions on Visualization and Computer Graphics 17, 2402–2411 (2011). 10. Goecks, J., Nekrutenko, A., Taylor, J. & the Galaxy Team. Genome Biology 11, R86 (2010). 11. Blankenberg, D. et al. Curr. Protoc. Mol. Biol. 89, 19.10.1–19.10.21 (2010). 12. Ron, D. & Walter, P. Nat. Rev. Mol. Cell Biol. 8, 519–529 (2007). 13. Walter, P. & Ron, D. Science 334, 1081–1086 (2011). 14. Mori, K. J. Biochem. 146, 743–750 (2009). 15. Calfon, M. et al. Nature 415, 92–96 (2002). 16. Yanagitani, K., Kimata, Y., Kadokura, H. & Kohno, K. Science 331, 586–589 (2011). 17. Guo, H., Ingolia, N.T., Weissman, J.S. & Bartel, D.P. Nature 466, 835–840 (2010). 18. Reid, D.W. & Nicchitta, C.V. J. Biol. Chem. 287, 5518– 5527 (2012). share or publish the new visualization on the web. Trackster’s use of data subsets to reduce analysis computation time is applicable to a wide set of genomic tools. For instance, genomic interval operations (such as intersect and subtract), transcript assembly and quantification, and human variation analysis (such as SNP calling) are compatible with Trackster’s analysis approach. However, tools (such as some peak callers) that use data from many or all genomic regions to build a global model require additional support to work with Trackster. These tools must be run once in full to generate the model, and then the model can be stored in Galaxy and reused in Trackster. Transcript quantification in Cufflinks benefits from a global model, and Trackster makes use of it when it available. Alternatively, a tool (for example, a read mapper) may require all input data because it is not possible to identify, before runtime, a subset of input data needed to produce correct output in a particular genomic region. For such tools, dynamic filtering can be used to simulate running a tool using different parameters. In this approach, a tool’s parameters are relaxed so that many potential outputs are produced and attribute values are attached to output data. Filtering can then be used to observe the data that would be produced for particular parameter values. Visualization and data analysis tools are used in nearly all high-throughput sequencing experiments, yet too often they are not well integrated. Coupling visualization and analysis tools into a visual analysis environment where analysis output can be generated and visually assessed in real time is a powerful approach for computational science. Trackster provides an environment for interactive visual analysis that is widely applicable to many different high-throughput sequencing experiments. General visual analysis techniques that can be performed in Trackster include tool parameter-space visualization and exploration, systematic sweeps of parameter values and dynamic filtering. Trackster makes visual analysis possible for a wide variety of tools by leveraging the Galaxy framework, thereby tapping into the large collection of tools already integrated into Galaxy and providing a simple path for integrating additional tools into Trackster. This approach to tool integration enables popular, production-level tools, such as Cufflinks in our example, to be integrated into Trackster without modification to the tools themselves. In our experiment, Trackster’s visual analysis features made it possible to use interactive visualization to improve Cufflinks’ transcript assemblies via parameter-space exploration and to remove assembly artifacts using dynamic filtering. Trackster also supports collaborative visual analysis via web-based, fully functional shared visualizations that can be modified, extended, re-shared and published.

Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential.

MUC1 is a shared tumor antigen expressed on >80% of human cancers. We completed the first prophylactic cancer vaccine clinical trial based on a non-viral antigen, MUC1, in healthy individuals at-risk for colon cancer. This trial provided a unique source of potentially effective and safe immunotherapeutic drugs, fully-human antibodies affinity-matured in a healthy host to a tumor antigen. We purified, cloned, and characterized 13 IgGs specific for several tumor-associated MUC1 epitopes with a wide range of binding affinities. These antibodies bind hypoglycosylated MUC1 on human cancer cell lines and tumor tissues but show no reactivity against fully-glycosylated MUC1 on normal cells and tissues. We found that several antibodies activate complement-mediated cytotoxicity and that T cells carrying chimeric antigen receptors with the antibody variable regions kill MUC1+ target cells, express activation markers, and produce interferon gamma. Fully-human and tumor-specific, these antibodies are candidates for further testing and development as immunotherapeutic drugs.

Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia.

Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia